Market Cap 229.51M
Revenue (ttm) 176.23M
Net Income (ttm) -257.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -146.30%
Debt to Equity Ratio 0.00
Volume 4,330,300
Avg Vol 8,680,554
Day's Range N/A - N/A
Shares Out 208.65M
Stochastic %K 20%
Beta 1.29
Analysts Strong Sell
Price Target $5.50

Latest News on SGMO

Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet

Dec 31, 2024, 12:01 PM EST - 17 days ago

Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet


Sangamo Follow-Up: Giro-Vec And STAC-BBB? Check.

Oct 21, 2024, 10:35 AM EDT - 3 months ago

Sangamo Follow-Up: Giro-Vec And STAC-BBB? Check.